Tech Company Financing Transactions
Galleon Pharmaceuticals Funding Round
Galleon Pharmaceuticals closed a $25 million investment round on 12/31/2014. Investors included BioAdvance Ventures, Morgenthaler Ventures and private investors.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3701 Market St. 5th Floor
Philadelphia, PA 19044
USA
Philadelphia, PA 19044
USA
Phone
Website
Email Address
Overview
Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Oliveto
Chief Medical Officer
James McLeod
Browse more venture capital transactions:
Prev: 12/31/2014: IronPlanet venture capital transaction
Next: 12/31/2014: Mitokyne venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs